PRASTERONE/AE - Search Results

Year	Number of Results
1971	1
1972	2
1973	2
1974	1
1975	3
1976	2
1978	1
1979	1
1983	2
1986	2
1988	4
1991	1
1992	4
1993	3
1994	3
1995	3
1996	3
1997	7
1998	11
1999	14
2000	7
2001	10
2002	12
2003	8
2004	7
2005	4
2006	16
2007	8
2008	10
2009	8
2010	5
2011	4
2012	4
2013	3
2014	3
2015	6
2016	7
2017	6
2018	10
2019	5
2020	6
2021	2

1

Prasterone.

Kocis P. Kocis P. Am J Health Syst Pharm. 2006 Nov 15;63(22):2201-10. doi: 10.2146/ajhp060100. Am J Health Syst Pharm. 2006. PMID: 17090740 Review.

2

Treatment of moderate to severe dyspareunia with intravaginal prasterone therapy: a review.

Portman DJ, Goldstein SR, Kagan R. Portman DJ, et al. Climacteric. 2019 Feb;22(1):65-72. doi: 10.1080/13697137.2018.1535583. Epub 2018 Dec 17. Climacteric. 2019. PMID: 30554531 Review.

3

Prasterone (Intrarosa) for dyspareunia.

[No authors listed] [No authors listed] Med Lett Drugs Ther. 2017 Sep 11;59(1529):149-150. Med Lett Drugs Ther. 2017. PMID: 28880846 No abstract available.

4

Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study.

Furat Rencber S, Kurnaz Ozbek S, Eraldemır C, Sezer Z, Kum T, Ceylan S, Guzel E. Furat Rencber S, et al. J Ovarian Res. 2018 Jun 29;11(1):55. doi: 10.1186/s13048-018-0427-7. J Ovarian Res. 2018. PMID: 29958542 Free PMC article.

5

Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy.

Sánchez-Guerrero J, Fragoso-Loyo HE, Neuwelt CM, Wallace DJ, Ginzler EM, Sherrer YR, McIlwain HH, Freeman PG, Aranow C, Petri MA, Deodhar AA, Blanton E, Manzi S, Kavanaugh A, Lisse JR, Ramsey-Goldman R, McKay JD, Kivitz AJ, Mease PJ, Winkler AE, Kahl LE, Lee AH, Furie RA, Strand CV, Lou L, Ahmed M, Quarles B, Schwartz KE. Sánchez-Guerrero J, et al. J Rheumatol. 2008 Aug;35(8):1567-75. Epub 2008 Jul 15. J Rheumatol. 2008. PMID: 18634158 Clinical Trial.

6

DHEA-induced ovarian hyperfibrosis is mediated by TGF-β signaling pathway.

Wang D, Wang W, Liang Q, He X, Xia Y, Shen S, Wang H, Gao Q, Wang Y. Wang D, et al. J Ovarian Res. 2018 Jan 10;11(1):6. doi: 10.1186/s13048-017-0375-7. J Ovarian Res. 2018. PMID: 29321035 Free PMC article.

7

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.

Labrie F, Archer DF, Koltun W, Vachon A, Young D, Frenette L, Portman D, Montesino M, Côté I, Parent J, Lavoie L, BSc AB, Martel C, Vaillancourt M, Balser J, Moyneur É; members of the VVA Prasterone Research Group. Labrie F, et al. Menopause. 2018 Nov;25(11):1339-1353. doi: 10.1097/GME.0000000000001238. Menopause. 2018. PMID: 30358731 Clinical Trial.

8

Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.

Petri MA, Lahita RG, Van Vollenhoven RF, Merrill JT, Schiff M, Ginzler EM, Strand V, Kunz A, Gorelick KJ, Schwartz KE; GL601 Study Group. Petri MA, et al. Arthritis Rheum. 2002 Jul;46(7):1820-9. doi: 10.1002/art.10364. Arthritis Rheum. 2002. PMID: 12124866 Free article. Clinical Trial.

9

Effects of prasterone (dehydroepiandrosterone) on markers of cardiovascular risk and bone turnover in premenopausal women with systemic lupus erythematosus: a pilot study.

Marder W, Somers EC, Kaplan MJ, Anderson MR, Lewis EE, McCune WJ. Marder W, et al. Lupus. 2010 Sep;19(10):1229-36. doi: 10.1177/0961203310371156. Epub 2010 Jun 8. Lupus. 2010. PMID: 20530522 Free article. Clinical Trial.

10

Prasterone (DHEA) and mania.

Dean CE. Dean CE. Ann Pharmacother. 2000 Dec;34(12):1419-22. doi: 10.1345/aph.10115. Ann Pharmacother. 2000. PMID: 11144700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results